Cisco
CSCO
Broadcom
AVGO
Taiwan Semiconductor
TSM
NVIDIA
NVDA
Apple
AAPL
US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 23.785
- -0.495-2.04%
Trading Mar 28 10:54 ET
2.99BMarket Cap-14.87P/E (TTM)
24.300High23.640Low128.84KVolume24.300Open24.280Pre Close3.08MTurnover0.15%Turnover RatioLossP/E (Static)125.52MShares59.91052wk High13.06P/B2.00BFloat Cap23.25052wk Low--Dividend TTM84.23MShs Float94.750Historical High--Div YieldTTM2.72%Amplitude11.450Historical Low23.889Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Apellis Pharmaceuticals Stock Forum
Breakthrough for Rare Kidney Diseases: EMA Reviews First Potential Treatment Following 68% Disease Reduction
finally moving
$Moderna (MRNA.US)$ $Apellis Pharmaceuticals (APLS.US)$ $Clover Health (CLOV.US)$
$Emergent BioSolutions (EBS.US)$
$Novocure (NVCR.US)$
No comment yet